|
Does it include her2 though?
I ask because her2 seems to change things. For example, the Oncotype DX test can be used to judge whether a patient is high enough risk to need chemo, but the U.S. National Comprehensive Cancer Network does not recommend using this test for her2 positive patient because Her2 positive patients invariably come out as intermediate or high risk.
|